within Pharmacolibrary.Drugs.ATC.N;

model N03AX13
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.9,
    Cl             = 1 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 400 / 1000000,
    adminCount     = 1,
    Vd             = 0.0005,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0008333333333333334,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Pheneturide is an aromatic acylurea-type antiepileptic drug that was historically used for the treatment of epilepsy. Due to safety concerns, adverse effects, and the availability of more effective anticonvulsants, pheneturide is rarely used in modern clinical practice and is not approved in many countries today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters are based on sparse historical literature and general estimates for adults after oral administration.</p><h4>References</h4><ol><li><p>Vachta, J, et al., &amp; Gold-Aubert, P (1986). Metabolism of pheneturide in the rat and in man. <i>European journal of drug metabolism and pharmacokinetics</i> 11(3) 195â€“204. DOI:<a href=&quot;https://doi.org/10.1007/BF03189847&quot;>10.1007/BF03189847</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3816875/&quot;>https://pubmed.ncbi.nlm.nih.gov/3816875</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end N03AX13;
